Nicholas Company’s Cardiovascular Systems, Inc. CSII Stock Holding History

Nicholas Company’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,895	Closed	-$43K	–	223
2015 Q4	$43K	Sell	2,895 -63,000	-96%	-$935K	﹤0.01%	209
2015 Q3	$1.04M	Sell	65,895 -42,915	-39%	-$1.08M	0.02%	198
2015 Q2	$2.88M	Buy	108,810 +15,245	+16%	+$492K	0.05%	191
2015 Q1	$3.65M	Hold	93,565	–	–	0.07%	181
2014 Q4	$2.81M	Buy	93,565 +2,575	+3%	+$73.6K	0.06%	196
2014 Q3	$2.15M	Buy	+90,990	New	+$2.59M	0.05%	209

Other funds holding CSII

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nicholas Company's CSII Position: Q1 2016 in Review

Nicholas Company sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2016, closing a stake of 2,895 shares — an estimated $43K sold.

Nicholas Company first reported a position in CSII in Q3 2014 and held it in 6 quarters. The position peaked at $3.65M in Q1 2015. 97 funds tracked by Wall St. Rank hold CSII as of Q1 2016.

Nicholas Company reported no remaining Cardiovascular Systems, Inc. position as of Q1 2016 after selling out during the quarter.
Nicholas Company sold 2,895 Cardiovascular Systems, Inc. shares in Q1 2016, an estimated $43K.
Nicholas Company first reported a position in Cardiovascular Systems, Inc. in Q3 2014 and held it in 6 quarters.
Nicholas Company's Cardiovascular Systems, Inc. position peaked at $3.65M in Q1 2015.
97 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2016.

Based on Nicholas Company's 13F filing for Q1 2016, filed 13 May 2016.